Carolinas HealthCare System

Research and Clinical Trials

Title  
ALK9072-A401
Brief Description  
The purpose of this research study is to test the safety and effectiveness of aripiprazole lauroxl in adults with schizophrenia who switch treatment from paliperidone palmitate to aripiprazole lauroxil.
Who may be Eligible  
male and female ages 18-65
IRB Number  
07-16-02A
Principal Investigator  
Tcheremissine, Oleg
Contact Name  
Dineen

For More Information, Contact   Dineen  Gardner , BA
Phone:  (704) 446-7511  Fax:  (704) 446-7505 
Email:  Dineen.Gardner@carolinashealthcare.org
Address:  465 North Wendover Road
Charlotte, NC
Close